BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11394581)

  • 1. The presence or absence of ribonucleotide reductase activity has no affect on avirulent bovine herpesvirus 2.
    Germano SJ; May JT
    Acta Virol; 2001 Feb; 45(1):65-6. PubMed ID: 11394581
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of thymidine kinase activity in a potential bovine herpesvirus 2 vaccine does not increase its virulence.
    Paxman JJ; Enriquez AM; May JT
    Acta Virol; 2000 Feb; 44(1):57-9. PubMed ID: 10989694
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of a thymidine kinase-deficient bovine herpesvirus 2 that still causes disease.
    Handley A; Puclin J; May JT
    Aust Vet J; 1996 Aug; 74(2):158-9. PubMed ID: 8894027
    [No Abstract]   [Full Text] [Related]  

  • 4. Loss of thymidine kinase activity due to a base deletion in a candidate vaccine strain of bovine herpesvirus 2.
    Gaut R; May JT
    Acta Virol; 1997 Apr; 41(2):93-5. PubMed ID: 9219639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location and characterization of the bovine herpesvirus type 2 thymidine kinase gene.
    Sheppard M; May JT
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():3067-71. PubMed ID: 2555436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals.
    Flores EF; Osorio FA; Zanella EL; Kit S; Kit M
    J Vet Diagn Invest; 1993 Oct; 5(4):534-40. PubMed ID: 8286451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acute outbreak of teat lesions affecting 38% of a dairy herd in Northland.
    Petrovski KR
    N Z Vet J; 2005 Apr; 53(2):162-3. PubMed ID: 15846404
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation and characterization of koi herpesvirus recombinants lacking viral enzymes of nucleotide metabolism.
    Fuchs W; Fichtner D; Bergmann SM; Mettenleiter TC
    Arch Virol; 2011 Jun; 156(6):1059-63. PubMed ID: 21387205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology of bovine herpesvirus 2 and herpes simplex virus 1 proteins.
    May JT
    Acta Virol; 2001 Jun; 45(3):197-9. PubMed ID: 11774900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the activity of thymidine kinase, ribonucleotide reductase and DNA-polymerases during the development of leukemia P388 in mice].
    Dederer LIu; Sokolova IS; Gudtsova KV; Gorbacheva LB
    Dokl Akad Nauk SSSR; 1990; 313(1):219-22. PubMed ID: 2090418
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of bovine mammillitis virus towards preparation of an alternative vaccine against herpes simplex virus infections of human subjects.
    Skinner GR; Buchan A; Durham J; Cowan M; Davies J; Brookes K; Castrucci G
    Vaccine; 1987 Mar; 5(1):55-9. PubMed ID: 3033927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bovine herpes mammillitis: clinical symptoms and serologic course].
    Janett F; Stäuber N; Schraner E; Stocker H; Thun R
    Schweiz Arch Tierheilkd; 2000 Jul; 142(7):375-80. PubMed ID: 11008514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of six Australian isolates of Bovine herpes virus 2 based on UL24 gene after a passage in MDBK cells.
    May JT
    Acta Virol; 2002; 46(3):175-8. PubMed ID: 12580380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody-based ELISA allows discrimination between responses induced by bovine herpesvirus subtypes 1 (BoHV-1.1) and 2 (BoHV-1.2).
    Spilki FR; Esteves PA; da Silva AD; Franco AC; Rijsewijk FA; Roehe PM
    J Virol Methods; 2005 Nov; 129(2):191-3. PubMed ID: 16046004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinkering with a viral ribonucleotide reductase.
    Lembo D; Brune W
    Trends Biochem Sci; 2009 Jan; 34(1):25-32. PubMed ID: 18990579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine kinase.
    Kit S
    Microbiol Sci; 1985 Dec; 2(12):369-75. PubMed ID: 3939993
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
    Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
    J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action.
    Uppsten M; Färnegårdh M; Domkin V; Uhlin U
    J Mol Biol; 2006 Jun; 359(2):365-77. PubMed ID: 16631785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UL24 consensus regions of bovine herpesvirus 2 isolate 554 and clinical isolates of herpes simplex viruses 1 and 2.
    Jelic I; May JT
    J Gen Appl Microbiol; 2003 Dec; 49(6):363-6. PubMed ID: 14747979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.